News from NYU Langone Health
Controlling Blood Sugar Slashes Heart Health Risks
AARP
Controlling high blood sugar is crucial for cardiovascular health, as elevated glucose can damage blood vessels, increase inflammation, and contribute to atherosclerosis and heart failure. The article emphasizes that early intervention is key. According to Jonathan Newman, MD, associate professor of medicine at the NYU Grossman School of Medicine and clinical research director at NYU Langone’s Center for the Prevention of Cardiovascular Disease, the prediabetic stage is a critical time to focus on preventative measures. He notes that acting early can significantly reduce the future risk of developing both diabetes and heart disease.
Also reporting was: The State, Miami Herald
12/23/2025
How Next-Generation Myosin Inhibitors Work in Hypertrophic Cardiomyopathy
HealthCentral
Hypertrophic cardiomyopathy (HCM) can be difficult to diagnose as its symptoms are often attributed to other conditions like anxiety, according to Daniele Massera, MD, associate director of the Hypertrophic Cardiomyopathy Program at NYU Langone Health. While traditional treatments manage symptoms, new-generation myosin inhibitors are changing the landscape by targeting the root cause. The FDA has approved one such drug, mavacamten, for obstructive HCM. However, Dr. Massera notes these drugs are not effective for non-obstructive HCM, and further research is needed for those patients.
12/23/2025
Wegovy Pill Wins FDA Approval as First GLP-1 Oral Treatment for Obesity and Weight Loss
Everyday Health
The U.S. Food and Drug Administration has approved the first oral GLP-1 treatment for weight management, a once-daily Wegovy pill. The approval is for adults with overweight or obesity and at least one related health issue. A clinical trial showed participants lost an average of 13.6% of their starting body weight. According to Melanie Jay, MD, associate professor in the Departments of Medicine and Population Health at NYU Grossman School of Medicine and director of the NYU Langone Comprehensive Program on Obesity, the gastrointestinal side effects of the pill are broadly comparable to the injectable versions of the drug.
12/23/2025
2026 Outlook: Dozens of healthcare CEOs retired in 2025—here are some of their parting thoughts
Fierce Healthcare
Dozens of healthcare CEOs retired in 2025, including Robert I. Grossman, MD, chief executive officer of NYU Langone Health and dean of NYU Grossman School of Medicine. The list of departing leaders also includes Michael Dowling of competitor Northwell Health. The article features parting thoughts from several retiring association heads, who discuss key industry challenges such as rising costs, maintaining coverage, rebuilding trust in institutions, and the need for greater efficiency and technology adoption to ensure the healthcare sector's long-term sustainability.
12/24/2025
Autoimmune diseases can strike any part of the body
The Times News
New research is offering the prospect of treatments that could reprogram the immune system to combat autoimmune diseases, which are on the rise. Dozens of clinical trials are testing new methods, with CAR-T therapy showing early success against lupus and other illnesses. Commenting on these developments, Amit Saxena, MD, director, Rheumatology Clinical Research Program at NYU Langone Health, stated, “This is probably the most exciting time that we’ve ever had to be in autoimmunity.” The article also discusses the challenges of diagnosing these conditions and potential triggers, such as the Epstein-Barr virus.
12/23/2025
Professor of Medicine Says Death Appears to Be Reversible
Lifeboat Foundation
In an interview, Sam Parnia, MD, PhD, associate professor in the Department of Medicine at NYU Langone Health, stated that death may be reversible with current medical interventions. He argued that the medical industry is behind on the concepts of death and dying. According to Parnia, recent studies, including some from his own lab at NYU Langone, suggest that the human brain can remain salvageable for hours or even days after the heart stops.
12/23/2025
